|
Verkman Grant Support (~$3,000,000/yr direct costs)
NIH CRISP database link: http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen
| Active Funding |
NIH R37 DK35124, 4/1/99-3/31/09 (MERIT award)
"Mechanisms of water transport in renal epithelia"
Principal Investigator: AS Verkman |
NIH R37 EB00415, 4/1/07-3/31/12 (MERIT award)
"Application of novel optical methods to cell dynamics"
Principal Investigator: AS Verkman |
NIH R01 EY13574, 9/1/07-8/31/12
"Role of aquaporin water channels in eye physiology"
Principal Investigator: AS Verkman |
NIH R01 HL73856, 9/1/07-8/31/11
"Role of ASL and glands in CF lung disease"
Principal Investigator: AS Verkman |
NIH R01 HL59198, 9/1/04-8/31/09
"Physiology and molecular biology of lung water transport"
Principal Investigator: AS Verkman |
NIH R01 DK75302, 8/1/06-6/30/11
"Targeting diseases caused by protein misfolding or misprocessing"
Principal Investigator: GL Lukacs; Co-investigator/subcontract: AS Verkman |
NIH P30 DK72517, 8/1/05-7/31/10
"Novel small-molecule therapies for CF" (Cystic Fibrosis Research and Translational Core Center)
Program Director: AS Verkman; Project leader (Cores 1, 3 and administrative core) |
Cystic Fibrosis Foundation Research Development Program R613, 8/1/07-7/31/11
"CF disease mechanisms and new therapies"
Program Director: AS Verkman; Project leader (Core 1, administrative core) |
Cystic Fibrosis Foundation VERKMA02WO, 4/1/00-12/31/10
"High-throughput screening for CF drug discovery"
Program Director: AS Verkman |
| |
| Industry Subcontract/Gift Support |
|
Biomarin Pharmaceuticals (Novato, CA) (12/08 - present) |
|
Napo Pharmaceuticals (South San Francisco, CA) (11/08 - present)
|
|